COVID-19 Trends and Forecast in the Eastern Mediterranean Region With a Particular Focus on Pakistan
Overview
Authors
Affiliations
First reported in China, the coronavirus responsible for coronavirus disease 2019 (COVID-19) has spread to 213 countries and territories around the world as of April 26, 2020. This study was designed to explore COVID-19 trends in the Eastern Mediterranean Region (EMR), with a particular focus on Pakistan. Daily reports and updates from the Ministry of National Health Services Regulations and Coordination COVID-19 Pakistan and the European Centre for Disease Prevention and Control were collected and study-specific data were extracted and analyzed. Our analysis revealed that, as of April 26, 2020, a total of 22 countries and territories in the EMR have reported COVID-19 cases. Iran had the highest number of cases (89,329) followed by Saudi Arabia (16,299), Pakistan (12,723), and the United Arab Emirates (9,813). Egypt (7.1%), Iran (6.3%), and Iraq (4.9%) had high case fatality rates; Lebanon (3.4%) and Pakistan (2.1%) had moderate case fatality rates; Saudi Arabia and the United Arab Emirates had low case fatality rates of 0.8% and 0.7%, respectively. Iran (76.3%) and Iraq (69.4 %) had the highest recovery rate followed by Pakistan (22.5%), the United Arab Emirates (19.2%), and Saudi Arabia (13.6%). If the current trend continues, based on the susceptible, infected, recovered (SIR) epidemiological model, we predict that EMR countries might experience a surge in the number of COVID-19 cases, resulting in as many as 2.12 million cases in Iran, 0.58 million in Saudi Arabia, and 0.51 million in Pakistan by June 20, 2020. Pakistan is the most populated country in the EMR and was the third most-affected country in terms of the number of cases with moderate case fatality and recovery rates. We predict that Pakistan's weak healthcare system would not be able to sustain care if there is an explosive increase in the number of cases due to insufficient and inconsistent disease prevention and control policies. The best strategy for mitigating the COVID-19 pandemic is to strictly follow recommendations based on epidemiological principles.
Antibiotic resistance and the COVID-19 pandemic: A dual crisis with complex challenges in LMICs.
Gulumbe B, Sahal M, Abdulrahim A, Faggo A, Yusuf Z, Sambo K Health Sci Rep. 2023; 6(9):e1566.
PMID: 37711678 PMC: 10498429. DOI: 10.1002/hsr2.1566.
Prediction of COVID-19 Using a WOA-BILSTM Model.
Yang X, Li S Bioengineering (Basel). 2023; 10(8).
PMID: 37627768 PMC: 10451184. DOI: 10.3390/bioengineering10080883.
Ali M Scientometrics. 2022; 127(6):3083-3115.
PMID: 35694422 PMC: 9173660. DOI: 10.1007/s11192-022-04391-w.
Epidemiological Study of COVID-19 in Iran and the World: A Review Study.
Ansari N, Shokri S, Pirhadi M, Abbaszadeh S, Manouchehri A Infect Disord Drug Targets. 2022; 22(8):30-41.
PMID: 35619250 DOI: 10.2174/1871526522666220526165012.
Jin W, Dong S, Yu C, Luo Q Comput Biol Med. 2022; 146:105560.
PMID: 35551008 PMC: 9042415. DOI: 10.1016/j.compbiomed.2022.105560.